DNA Research Advance Access originally published online on February 22, 2006
DNA Research 2006 13(1):37-42; doi:10.1093/dnares/dsi024
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ultra-Sensitive Immunodetection of 5'Methyl Cytosine for DNA Methylation Analysis on Oligonucleotide Microarrays
1 Elisabethinen Hospital, 1st Department of Internal Medicine Fadingerstrasse 1, A-4010 Linz, Austria
2 Upper Austrian Research GmbH, Center for Biomedical Nanotechnology Scharitzer Strasse 6, A-4020 Linz, Austria
Received 20 October 2005; revised 12 December 2005
| Abstract |
|---|
|
|
|---|
For the determination of methylation levels in genomic regulatory DNA sequences a high-sensitive assay for detecting 5'methyl-cytosines (5'mC) in non-bisulfite-treated DNA has been established. The system is designed for the application of immunofluorescence using a monoclonal antibody that specifically recognizes 5'mC in single-stranded DNA hybridized to oligonucleotide microarrays. For assay readout an ultra-sensitive fluorescence scanner with submicrometer resolution was used. To minimize autofluorescence 150-µm thin glass slides with an aldehyde-functionalized surface were developed. These methodological improvements allowed the detection of 5'mC in synthetic oligonucleotides hybridized to microarrays with atto molar analytical sensitivity. Using enzymatic fragmented genomic DNA from myeloid leukemia tumor cell lines differences in the methylation status of gene regulatory sequences for E-cadherin, p15/CDKN2b and p16/CDKN2a were demonstrated. Thus, this novel technique can potentially be used for DNA methylation analysis in various scientific fields.
Key words: epigenetics; DNA methylation; oligonucleotide microarray; immunofluorescence
| 1. Introduction |
|---|
|
|
|---|
The regulation of gene expression by epigenetic mechanisms such as cytosine methylation contributes to various biological processes like parental genomic imprinting, X-chromosomal inactivation, cellular differentiation and aging as well as the development of malignant disorders.1
| 2. Materials and Methods |
|---|
|
|
|---|
2.1. Cell lines and genomic DNA preparation
Human acute myeloid leukemia (AML) cell lines HL-60 (American Type Culture Collection) and KG1a (Deutsche Sammlung von Mikroorganismen und Zellkulturen, DSMZ, Braunschweig, Germany) were grown in RPMI-1640 medium (Gibco Invitrogen, Paisley, Scotland) supplemented with 10% FCS (Gibco), L-glutamine (300 mg/l; Gibco) and antibiotics [Streptomycin (100 µg/ml)/Penicillin (100 U/ml); Gibco]. Both cell lines are extensively described and epigenetically characterized.10
2.2. Methyl-specific PCR (MS-PCR)
Chemicals and oligonucleotides were purchased at Sigma-Aldrich Chemie GmbH, Steinheim, Germany and Metabion GmbH, Munich, Germany, respectively. Methyl-specific PCR (MS-PCR) was performed with primer sequences as published by Herman et al.14
Minor modifications concerned the use of HotStarTaq DNA polymerase (5 U/µl; Qiagen, Hilden, Germany), sodium-bisulfite treatment at 55°C for 4 h and 40 PCR cycles in a Primus 96plus MWG-biotech thermal cycler starting with 400 ng bisulfite-treated DNA. All PCRs were performed with positive controls for both unmethylated and methylated alleles. PCR products were analyzed by electrophoresis on 1% agarose gels and ethidium bromide staining.
2.3. Microarray production
To minimize background fluorescence we used borosilicate glass slides (50 x 24 x 0.15 mm3; Stölzle-Oberglas, Austria) with an aldehyde surface obtained by standard surface chemistry.15
Amino-modified capture oligonucleotides were coupled to the slide surface by reductive amination.
2.4. Capture oligonucleotide dilution and spotting process
Sense capture oligonucleotides were diluted to 5 µM in 1x SSC [15 mM sodium citrate, 150 mM sodium chloride, pH 7.0 with 2.5% glycerol (Sigma-Aldrich)]. The contact spotting robot (SpotBot), from ArrayIt, CA, was used with Tungsten Split Pins (PT3000; Point Technologies, Boulder, CO) for the microarray printing process, resulting in spots of
50-µm diameter with a volume of 100 pl. Oligonucleotide immobilization was performed at room temperature by incubation in a humid environment for 12 h. For stabilization of the intermediary carbonnitrogen double bond between aldehyde surface and amino-modified capture oligonucleotides to form a secondary amine, sodium cyanoborohydride [0.02 M in 0.1 M carbonate buffer; pH 8.2 (Sigma-Aldrich)] was applied by additional 2 h incubation. After a 15 min washing step in carbonate buffer (0.1 M; pH 8.2) microarrays were dried and immediately used for hybridization experiments.
2.5. Capture oligonucleotide design
Capture oligonucleotide design was based upon analyses of predicted promoter sequences for possible methylation sites (CpG islands).14
,16
Capture oligonucleotides suitable to hybridize to DNA-targets generated by restriction enzyme digestion of genomic DNA were designed using OligoWiz software (Center for Biological Sequence Analysis BioCentrum-DTU Technical University of Denmark). Sequence information concerning capture and hybridization oligonucleotides (VBC-genomics, Vienna, Austria) including modifications and fluorescence labels are summarized in Table 1.
|
2.6. Hybridization experiments
Hybridizations were performed at 55°C (oligonucleotides) or 65°C (genomic DNA), respectively, in a hybridization buffer mix containing 4x SSC and 0.1% SDS (Sigma-Aldrich, Chemie). The used surface inactivation (sodiumcyanoborohydride buffer) and blocking conditions [0.2% BSA (Sigma-Aldrich) in Dulbecco's phosphate-buffered saline (PBS; Gibco)] allowed to omit prehybridization or the use of competitive DNA. For single subgrid hybridization (2.5-µl hybridization mixtures) 5 mm diameter cover slips, (Menzel Gläser, Braunschweig, Germany) and for multiple subgrid hybridization (10 µl hybridization mix) 22 x 22 mm2 cover slips (Assistent, Sondheim, Germany) were used in Corning hybridization chambers (Fischer Scientific, Loughborough, UK) submerged in a water bath. After overnight hybridization washes were performed with 2x SSC, 0.01% SDS for 15 min, 2x SSC for 15 min and 0.2x SSC for 15 min with all washing solutions preheated to 42°C.
2.7. Microarray immunolabeling
Slides were blocked for 30 min at room temperature with 0.2% BSA in Dulbecco's PBS and incubated with a monoclonal anti-5'mC antibody (clone: 33D3; mouse IgG1; Serotec, Düsseldorf, Germany) or isotype-matched control antibody (anti-collagen clone: COL-1; mouse IgG1) diluted in PBSBSATween [BSA 0.1%; Tween-20 0.05% (Sigma-Aldrich Chemie)] for 1 h at room temperature at a concentration of 1 µg/ml each. Primary antibody incubation was followed by a washing step in PBS for 5 min and secondary antibody incubation (cyanine 3 dye conjugated secondary goat anti-mouse antibody; 1 : 2000 diluted in PBSBSATween, Amersham) for 1 h at room temperature. After three 5 min washing steps in PBS, microarrays were dried and scanned immediately.
2.8. Ultra-sensitive microarray readout
The device applies a novel readout technology that combines wide-field illumination as well as time delay and integration (TDI) mode for readout.9
In brief, the apparatus used in our measurements comprises an inverted microscope (Axiovert 200, Zeiss, Germany), a high-precision scanning stage (Märzhäuser Wetzlar, Germany) and a charge-coupled device camera (CCD camera) with high quantum efficiency and low readout noise running in TDI mode (CoolSNAP HQ, Photometrics, Roper Scientific, USA). For illumination of cyanine 3 and cyanine 5 we used an Nd : Yag laser (Neodym-Ion doted YttriumAluminiumGranat) with
= 532 nm (Millennia II, Spectra-Physics, USA) and a Krypton-Ion laser with
= 647 nm (43 Series Ion Laser, Melles Griot, USA), respectively. High laser intensities, x100 optical magnification (0.516 nm pixel resolution) and short exposure times (250 ms) allowed ultra-sensitive microarray readout within minutes.
2.9. Image analysis and statistics
For image and data analysis we used ImaGene® 5.6 (BioDiscovery, CA, USA) together with ArrayNorm® 1.7 (Graz University of Technology Bioinformatics Group, Austria),17
a software for array normalization and data visualization control. After background correction, statistical analysis of fluorescence signal intensities comparing the cell lines was done with two-tailed Student's t-test.
| 3. Results and discussion |
|---|
|
|
|---|
Designed amino-modified and fluorescence-labeled capture oligonucleotides were spotted on to the aldehyde surface-coated glass cover slips, hybridized with selected target oligonucleotides or enzyme digested genomic DNA. The consecutive indirect anti-5mC antibody staining was followed by readout on the fluorescence scanning platform (schematically outlined in Fig. 1). Cell line and target gene selection were based solely on well-established promoter/gene methylation models: E-cadherin, p15/CDKN2b and p16/CDKN2a from two AML-derived tumor cell lines (HL-60, KG1a). To validate the results obtained with the anti-5'mC microarray we analyzed representative CpG-island containing DNA fragments by MS-PCR.
|
3.1. Antibody specificity
To test the anti-5mC antibody specificity (Clone 33D318
3.19
|
3.2. Assay sensitivity
Hybridization experiments were performed with sense and nonsense capture oligonucleotides hybridized with a series of increasing target oligonucleotide concentrations (600 aM to 38.4 fM; Fig. 3). Signals of 10 repeats from 2 hybridization experiments plotted against the target oligonucleotide concentration are linear (R2 = 0.96) from 600 aM to 38.4 fM. On a minimal slide background the 5'-mC-specific signals resulted in an SNR of 8 (mfi/SD 18/8) for the 600 aM spot and up to an SNR of 83 (mfi/SD 249/125) for the 38.4 fM spot. Signal intensities for target oligonucleotide hybridized to nonsense capture oligonucleotide are similar to slide background. A detection limit at 600 aM target oligonucleotide represents 1.5 fg DNA per hybridization volume of 3 µl, corresponding to the DNA content of nuclei from 540 cells. The detection limit of methylation-specific PCR is in the range of 50500 pg DNA representing 10100 cells.20
|
3.3. MS-PCR
MS-PCR was done using DNA from the cell lines HL-60 and KG1a which are well characterized with regard to the methylation status of p15/CDKN2b, p16/CDKN2a and E-cadherin promoter regions.14
|
3.4. Genomic DNA hybridization
Microarray capture oligonucleotides and restriction enzymes were designed to bind and cut exactly the same CpG islands detected by MS-PCR. MnlI digest result in a 147 bp fragment for p15/CDKN2b and a 111 bp fragment for p16/CDKN2a including the region amplified by MS-PCR. MnlI digest concerning E-cadherin results in a 105 bp fragment in the preproprotein region for E-cadherin, a hypermethylated CpG region in certain tumors.21
|
Unlike other currently used methods, such as bisulfite conversion dependent MS-PCR or microarray techniques which focus on sequence details within individual primer pairs or capture oligonucleotide sequences, the presented method is capable of detecting all methylated cytosines per hybridized DNA fragment at once. Moreover our approach can be used for any region of the genome whether or not methylation-sensitive restriction enzyme sites are present. Practically, as a consequence of target DNA length (less than few hundred nucleotides), hybridization specificity can be optimized with the possibility to reduce the capture oligonucleotide numbers significantly compared with other microarray techniques for DNA methylation analysis.
| 4. Conclusion |
|---|
|
|
|---|
We have examined the feasibility of a novel microarray for 5'mC detection using immunofluorescence measurement. This method combines the advantages of microarray technology (high-throughput), fluorescence detection (high sensitivity) and immunolabeling (high specificity) and might become an adequate tool for investigating DNA methylation in various scientific fields.
| Acknowledgements |
|---|
|
|
|---|
This project was supported by the Austrian Federal Ministry for Education, Science and Culture in the context of the Gen-AU project Ultra sensitive Proteomics and Genomics. AML cell lines are generous gifts from H. Stockinger, Vienna. We thank A. Sonnleitner and G. J. Schütz for excellent consultation and helpful discussions.
| Footnotes |
|---|
*To whom correspondence should be addressed. Tel. +43-732-6060-7929, Fax. +43-732-6060-7930, E-mail: johannes.proell{at}uar.at
| References |
|---|
|
|
|---|
- Ferguson-Smith, A. C. and Surani, M. A. 2001, Imprinting and the epigenetic asymmetry between parental genomes, Science, 293, 10861089.
[Abstract/Free Full Text] - Lee, J. T. 2003, Molecular links between X-inactivation and autosomal imprinting: X-inactivation as a driving force for the evolution of imprinting?, Curr. Biol., 13, R242254.[CrossRef][Web of Science][Medline]
- Issa, J. P. 2003, Age-related epigenetic changes and the immune system, Clin. Immunol., 109, 103108.[CrossRef][Web of Science][Medline]
- Robertson, K. D. 2005, DNA methylation and human disease, Nat. Rev. Genet., 6, 597610.[CrossRef][Web of Science][Medline]
- Ushijima, T. 2005, Detection and interpretation of altered methylation patterns in cancer cells, Nat. Rev. Cancer, 5, 223231.[CrossRef][Web of Science][Medline]
- Shiraishi, M. and Hayatsu, H. 2004, High-speed conversion of cytosine to uracil in bisulfite genomic sequencing analysis of DNA methylation, DNA Res., 11, 409415.[Abstract]
- Derks, S., Lentjes, M. H., Hellebrekers, D. M., de Bruine, A. P., Herman, J. G., van Engeland, M. 2004, Methylation-specific PCR unraveled, Cell Oncol., 26, 291299.[Web of Science][Medline]
- Hinterdorfer, P., Schutz, G., Kienberger, F., Schindler, H. 2001, Detection and characterization of single biomolecules at surfaces, J. Biotechnol., 82, 2535.[CrossRef][Medline]
- Hesse, J., Sonnleitner, M., Sonnleitner, A. 2004, Single-molecule reader for high-throughput bioanalysis, Anal. Chem., 76, 59605964.[Medline]
- Cottier, M., Tchirkov, A., Perissel, B., Giollant, M., Campos, L., Vago, P. 2004, Cytogenetic characterization of seven human cancer cell lines by combining G- and R-banding, M-FISH, CGH and chromosome- and locus-specific FISH, Int. J. Mol. Med., 14, 483495.[Medline]
- Mrozek, K., Tanner, S. M., Heinonen, K., Bloomfield, C. D. 2003, Molecular cytogenetic characterization of the KG-1 and KG-1a acute myeloid leukemia cell lines by use of spectral karyotyping and fluorescence in situ hybridization, Genes Chromosomes Cancer, 38, 249252.[CrossRef][Medline]
- Farinha, N. J., Shaker, S., Lemaire, M., Momparler, L., Bernstein, M., Momparler, R. L. 2004, Activation of expression of p15, p73 and E-cadherin in leukemic cells by different concentrations of 5-aza-2(-deoxycytidine (Decitabine), Anticancer Res., 24, 7578.
[Abstract/Free Full Text] - Dodge, J. E., Munson, C., List, A. F. 2001, KG-1 and KG-1a model the p15 CpG island methylation observed in acute myeloid leukemia patients, Leuk. Res., 25, 917925.[CrossRef][Medline]
- Herman, J. G., Graff, J. R., Myohanen, S., Nelkin, B. D., Baylin, S. B. 1996, Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands, Proc. Natl Acad. Sci. USA, 93, 98219826.
[Abstract/Free Full Text] - Schlapak, R., Pammer, P., Armitage, D. 2006, Glass surface grafted with high-density poly(ethylene glycol) as substrates for DNA oligonucleotide microarrays, Langmuir., 22, 277285.[Medline]
- Takai, D. and Jones, P. A. 2003, The CpG island searcher: a new WWW resource, In Silico Biol., 3, 235240.[Medline]
- Pieler, R., Sanchez-Cabo, F., Hackl, H., Thallinger, G. G., Trajanoski, Z. 2004, ArrayNorm: comprehensive normalization and analysis of microarray data, Bioinformatics, 20, 19711973.
[Abstract/Free Full Text] - Reynaud, C., Bruno, C., Boullanger, P., Grange, J., Barbesti, S., Niveleau, A. 1992, Monitoring of urinary excretion of modified nucleosides in cancer patients using a set of six monoclonal antibodies, Cancer Lett., 61, 255262.[CrossRef][Web of Science][Medline]
- Hardiman, G. 2003, Microarray methods and applications, 1st ed. Eagleville, Pennsylvania DNA-press99114.
- Olek, A., Oswald, J., Walter, J. 1996, A modified and improved method for bisulphite based cytosine methylation analysis, Nucleic Acids Res., 24, 50645066.
[Abstract/Free Full Text] - Graziano, F., Arduini, F., Ruzzo, A., et al. 2004, Prognostic analysis of E-cadherin gene promoter hypermethylation in patients with surgically resected, node-positive, diffuse gastric cancer, Clin. Cancer Res., 10, 27842789.
[Abstract/Free Full Text] - Brazma, A., Hingamp, P., Quackenbush, J., et al. 2001, Minimum information about a microarray experiment (MIAME)-toward standards for microarray data, Nat. Genet., 29, 365371.[CrossRef][Web of Science][Medline]
This article has been cited by other articles:
![]() |
Y. Li, Y. Cui, S. N. Hart, C. D. Klaassen, and X.-b. Zhong Dynamic Patterns of Histone Methylation Are Associated with Ontogenic Expression of the Cyp3a Genes during Mouse Liver Maturation Mol. Pharmacol., May 1, 2009; 75(5): 1171 - 1179. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. U. Mir Ultrasensitive RNA profiling: Counting single molecules on microarrays Genome Res., October 1, 2006; 16(10): 1195 - 1197. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






